Published in Clinical Oncology Week, November 27th, 2006
Study 1: Investigators publish new data in the report "Biomarkers in Diagnosis of pancreatic carcinoma in fine-needle aspirates. This study was undertaken to determine whether recently identified proteins could be translated to clinical practice as markers to distinguish pancreatic adenocarcinoma from chronic pancreatitis on fine-needle aspirate (FNA) samples. Resected pancreatic tissue sections (n=40) and FNA samples (n=65) were stained for clusterin-beta, MUC4, survivin, and mesothelin," investigators in the United States report.
"For each biomarker, the staining...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.